Scientists have found that people who survive Ebola have antibodies in their blood that would provide protection against that strain of the virus in the future, and possibly against other strains as well. But, as you can imagine, they haven't tested this theory by infecting survivors with the virus again.
So all these health professionals, experts and agencies basically:
-Have no plan.
-Can do nothing.
-Explain the disease as nature taking its course.
Useless bureaucrats doing nothing but making excuses. Cashier them all!
Ebola, if it gets out of hand looks like it could solve our man made global warming and reduce humanities carbon footprint.
Don’t be surprised if some Islamic terrorist don’t go and get infected in order to come to America to spread the Ebola virus instead of strapping a bomb and just blowing up.
But, I thought they were starving in Africa? How can the population grow by 300% if they couldn't feed themselves 40 years ago?
And this is not even the scariest bug running around right now. Sigh.
Michael Osterholm is a senior and very well respected clinician, scientist, and epidemiologist. He’s also very well-connected.
That he would publish this, at this time, and in the NYT, reflects the enormous tension that must exist today within the CDC bureaucracy. No junior scientist/epidemiologist who depends on CDC, or PHS in general for a paycheck could have ever written this.
I think Dr. Osterholm is absolutely correct that some type of incident command structure has to be put in place, and quickly.
Of course, the idea that the UN has some sort of capability along these lines is, well, a little off - but if I wanted to ring the alarm and I wanted to do it in the NYT, I might have said the same thing.
The airports and harbors in Guinea, Sierra Leone, and Liberia need to be closed, now, and only the Global Force for Good can do it. Closing Nigeria is several orders of magnitude more difficult, and the evidence in hand doesn’t show that it’s necessary (yet).
But allowing outbound flights from Monrovia, Freetown, Conakry (and probably Bamako) any more is just crazy. Within a month, you’re going to see plague ships trying to make the run to Brazil.
If Ebola was coming to the United States to vote Republican, the government would find a cure.
ping
A link to this thread has been posted on the Ebola Surveillance Thread
Marburg a few years back acted differently.
This will get out of control, because we won’t try to stop it.
That’s it. I’m committing suicide, rather than risk getting Ebola.
Airborne illnesses are NOT the same as respiratory droplet illnesses!!! While some may overlap in their mode of transmission (see recent discoveries re: influenza), in medical circles these terms mean very different things. The latter describes illnesses where viruses and bacteria are passed between people by clinging to relatively large droplets expelled during coughing/sneezing, which can only travel 1-2 meters in the air before succumbing to gravity and becoming much less of a threat. The former, on the other hand, describes conditions such as chicken pox and tuberculosis (and possibly influenza, through aeresolization) and others, where the infectious particles are small and light enough to be able to travel longer distances through the air, following air currents without being pulled down to the floor immediately. From what I can tell, while researchers do believe ebola (and flu) may be able to travel via large droplets, there is no evidence or suggestion thus far that ebola is possibly becoming airborne.
These distinctions are hugely important in terms of how one handles infections, as well as implications of infection in terms of others around the patient. Droplet precautions only require masks, gloves and sometimes gowns; AIRBORNE precautions require negative-pressure ventilation to ensure no/little transmission to others via a very infective route. Airborne is WAY more concerning in general, at least in terms of transmission. This is sloppy reporting at best.
This is a flat-out false statement, is totally unsubstantiated and is not even supported by the subsequent text.
PING!
Glad to oblige!
This is an official CDC HEALTH ADVISORY Distributed via the CDC Health Alert Network September 12, 2014, 17:00 ET (5:00 pm ET) CDCHAN-00369 Severe Respiratory Illness Associated with Enterovirus D68 – Multiple States, 2014 Summary: The Centers for Disease Control and Prevention (CDC) is working closely with hospitals and local and state health departments to investigate recent increases in hospitalizations of patients with severe respiratory illness. Enterovirus D68 (EV-D68) has been detected in specimens from children with severe illness in Missouri and Illinois. Investigations into suspected clusters in other jurisdictions are ongoing. The purpose of this HAN Advisory is to provide awareness of EV-D68 as a possible cause of acute unexplained respiratory illness, and to provide guidance to state health departments and health care providers. Please disseminate this information to infectious disease specialists, intensive care physicians, pediatricians, internists, infection preventionists, and primary care providers, as well as to emergency departments and microbiology laboratories. Background Enteroviruses are associated with various clinical symptoms, from mild to severe. EV-D68 causes primarily respiratory illness, although the full spectrum of disease remains unclear. EV-D68 was originally isolated in 1962 and, since then, has been reported rarely in the United States. Small clusters of EV-D68 associated with respiratory illness were reported in the United States during 2009–2010.There are no available vaccines or specific treatments for EV-D68, and clinical care is supportive. In August 2014, a children’s hospital in Kansas City, Missouri, and one in Chicago, Illinois, notified CDC of increases in pediatric patients examined and hospitalized with severe respiratory illness, including some admitted to pediatric intensive care units. Both hospitals also reported recent increases in detection of rhinovirus/enterovirus, in initial screening with a respiratory virus panel. Nasopharyngeal specimens from patients with recent onset of severe symptoms from both facilities were sequenced by the CDC Picornavirus Laboratory. EV-D68 was identified in 19 of 22 specimens from Kansas City and in 11 of 14 specimens from Chicago. Admissions for severe respiratory illness have continued at both facilities at rates higher than expected for this time of year. CDC has been notified by various states of similar clusters of respiratory illness, though confirmation of EV-D68 in these potential clusters is still under way. Of these severely ill patients who were confirmed positive for EV-D68 from both hospitals, all presented with difficulty breathing and hypoxemia, and some with wheezing. Notably, most patients were afebrile at presentation and throughout the hospital course. Approximately two thirds of cases had a previous medical history of asthma or wheezing, but both hospitals reported some patients with no known underlying respiratory illness. Ages ranged from 6 weeks through 16 years, with median ages of 4 and 5 years in Kansas City and Chicago, respectively. Most patients were admitted to the pediatric intensive care unit. Of the 30 patients who were positive for EV-D68, two required mechanical ventilation (one of whom also received extracorporeal membrane oxygenation) and six required bilevel positive airway pressure ventilation. It should be noted that specimens from only the most severe cases have been typed at this time, and so these findings may not reflect the full spectrum of disease. Additional details about these EV-D68 clusters can be found in the September 8, 2014, MMWR Early Release: (http://www.cdc.gov/mmwr/preview/mmwrhtml/mm63e0908a1.htm?s_cid=mm63e0908a1_e) Recommendations Clinical Care: • Health care providers should consider EV-D68 as a possible cause of acute, unexplained severe respiratory illness, even in the absence of fever. • Although the findings to date have been in children, EV-D68 may also affect adults. Laboratory Testing: • Providers should consider laboratory testing of respiratory specimens for enteroviruses when the cause of respiratory infection in severely ill patients is unclear. • Confirmation of the presence of EV-D68 requires typing by molecular sequencing. • Providers may contact state or local health departments for further enterovirus typing. CDC is available for consultation. • Health departments may contact CDC for further enterovirus typing. • CDC is currently prioritizing respiratory specimens from patients with severe respiratory illness who are known to be positive for rhinovirus/enterovirus from initial screening assays. • Please visit the CDC EV-D68 website (http://www.cdc.gov/non-polio-enterovirus/about/EV-D68.html) for information on specimen submission. Completion of a brief patient summary form is required with each specimen submission to CDC. Infection Control: • Routes of transmission for EV-D68 are not fully understood. • Infection control guidelines for hospitalized patients with EV-D68 infection should include standard precautions, and contact precautions in certain situations, as is recommended for all enteroviruses (http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf). • As EV-D68 is a cause of clusters of respiratory illness, similar to rhinoviruses, droplet precautions also should be considered as an interim recommendation until there is more definitive information available on appropriate infection control. • As EV-D68 is a non-enveloped virus, environmental disinfection of surfaces in healthcare settings should be performed using a hospital-grade disinfectant with an EPA label claim for any of several non-enveloped viruses (e.g. norovirus, poliovirus, rhinovirus). Disinfectant products should be used in accordance with the manufacturer’s instructions for the specific label claim and in a manner consistent with environmental infection control recommendations (http://www.cdc.gov/hicpac/pdf/guidelines/eic_in_HCF_03.pdf). Reporting: • Providers should report suspected clusters of severe respiratory illness to local and state health departments. • EV-D68 is not nationally notifiable, but state and local health departments may have additional guidance on reporting. • Health departments may contact CDC for epidemiologic support. Please contact Dr. Claire Midgley (cmidgley@cdc.gov) with brief descriptions of possible clusters. For more information: For additional information, please consult the CDC enterovirus D68 website: (http://www.cdc.gov/non-polio-enterovirus/about/EV-D68.html) The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and controlling diseases and injuries; enhances health decisions by providing credible information on critical health issues; and promotes healthy living through strong partnerships with local, national, and international organizations. ____________________________________________________________________________________ Categories of Health Alert Network messages: Health Alert Requires immediate action or attention; highest level of importance Health Advisory May not require immediate action; provides important information for a specific incident or situation Health Update Unlikely to require immediate action; provides updated information regarding an incident or situation HAN Info Service Does not require immediate action; provides general public health information ##This message was distributed to state and local health officers, state and local epidemiologists, state and local laboratory directors, public information officers, HAN coordinators, and clinician organizations##